GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » EPS (Diluted)

Hyphens Pharma International (SGX:1J5) EPS (Diluted) : S$0.03 (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International EPS (Diluted)?

Hyphens Pharma International's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was S$0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.03.

Hyphens Pharma International's EPS (Basic) for the six months ended in Jun. 2023 was S$0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.03.

Hyphens Pharma International's EPS without NRI for the six months ended in Jun. 2023 was S$0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.03.

During the past 12 months, Hyphens Pharma International's average EPS without NRIGrowth Rate was 3.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 18.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Hyphens Pharma International's highest 3-Year average EPS without NRI Growth Rate was 18.20% per year. The lowest was 3.60% per year. And the median was 5.70% per year.


Hyphens Pharma International EPS (Diluted) Historical Data

The historical data trend for Hyphens Pharma International's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International EPS (Diluted) Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
Get a 7-Day Free Trial 0.02 0.02 0.02 0.02 0.04

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.02 0.02 0.01

Competitive Comparison of Hyphens Pharma International's EPS (Diluted)

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyphens Pharma International's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's PE Ratio distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's PE Ratio falls into.



Hyphens Pharma International EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Hyphens Pharma International's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(11.351-0)/310.261
=0.04

Hyphens Pharma International's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.568-0)/310.261
=0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International  (SGX:1J5) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hyphens Pharma International EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International (SGX:1J5) Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines